Product Liability Lawyer Mitchell Alter is reviewing potential testosterone replacement products like ANDROGEL, TESTIM, and AXIRON. Victims in these cases state that the defendants failed to conduct proper research studies on their products before releasing them on the market, and failed to provide adequate warnings about potential side effects like heart attacks and strokes.
The FDA warned in January 2014 that they were investigating testosterone replacement therapy products because of two major studies that indicated the drugs could increase risk of cardiovascular health problems. One study published in the November 2013 Journal of the American Medical Association found older men with underlying cardiovascular disease who took testosterone medication had a 30% increased risk of having a stroke, heart attack or death compared to men who did not.
In March 2015, the FDA released another announcement stating they had required manufactures to add verbiage to their warning labels alerting doctors and patients to the risks of heart attacks, strokes, and death.
Common Low-T medications include Testim, manufactured by Auxilium, and AndroGel, manufactured by AbbVie Inc and Abbott Labs.
In June 2014, all federal testosterone lawsuits were consolidated into one court in the Northern District of Illinois, and there are presently over 2,500 cases pending.